Recherche
-
Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015)
(Frontiers in Pharmacology. vol. 12, pp. 682890, 2021-11-03)Article de revueLibre accès -
Use of real-world evidence in translational pharmacology research
(Fundamental & Clinical Pharmacology, 2021-10-21)Article de revue -
Use of IV Iron and Risk of Anaphylaxis: A Multinational Observational Post-Authorisation Safety Study in Europe
(Pharmacoepidemiology and Drug Safety, 2021-06-28)Article de revueLibre accès -
Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database
(Thérapie. vol. 76, n° 5, pp. 435-440, 2021-09)Article de revue -
Treatment resistant depression incidence and prevalence using the French nationwide claims database
(Pharmacoepidemiology and Drug Safety. vol. 30, n° 2, pp. 169–177, 2021-02)Article de revue -
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data
(BMC Medical Research Methodology. vol. 21, n° 1, pp. 95, 2021-05-01)Article de revueLibre accès -
Global epidemiology of hip fractures: a study protocol using a common analytical platform among multiple countries
(BMJ Open. vol. 11, n° 7, pp. e047258, 2021-07-28)Article de revueLibre accès -
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
(American Journal of Cardiovascular Drugs, 2021-12-21)Article de revue -
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database
(Cardiovascular Diabetology. vol. 20, n° 1, pp. 229, 2021-11-25)Article de revueLibre accès -
NSAIDs and COVID-19: A Systematic Review and Meta-analysis
(Drug Safety. vol. 44, n° 9, pp. 929-938, 2021-09)Article de revue